Training Grant

This NIH-funded T32 Training Grant in the Division of Infectious Diseases, the Columbia Integrated Training Program in Infectious Disease Research, is dedicated to supporting research training of fellows in their second and third years. Drs. Anne-Catrin Uhlemann and Magda Sobieszczyk serve as the PIs of this training grant.

This interdisciplinary training grant is designed to provide the fellows with the necessary skill set to successfully pursue translational research whether it is primarily basic, implementation science, or clinical/epidemiological. The objective is to train physician-scientists and public health leaders who integrate new technologies such as genomics, epidemiology, implementation science, and biomedical informatics into their research. The training opportunities are augmented by mentorship by faculty members in the division and other schools and departments across the university. to augment their research, fellows frequently take classes or pursue a master's, at the Mailman School of Public Health.

The  Columbia Integrated Training Program in Infectious Disease Research, our NIH-funded T32 training grant, provides opportunities for trainees to develop careers in academic medicine in basic, translational, clinical epidemiological, and implementation science research of infectious diseases. This is of critical importance to society, as the rise in antimicrobial resistance, and emergence of new pathogens such as SARS-CoV-2 are posing urgent public health threats. Get to know the talented faculty mentors involved in our ID T32 training grant program.

Our fellows are also able to take advantage of mentored research opportunities through the following training grants available at Columbia University Irving Medical Center: Postdoctoral Fellowship in Behavioral Sciences Research in HIV Infection  and the  Global HIV Implementation Science Research Training Fellowship

Areas of Focus

The Training Grant areas of focus and faculty mentors include:

Our fellows are also able to take advantage of mentored research opportunities through the training grants available at ICAP/Mailman School of Public Health and the HIV Center for Clinical and Behavioral Studies at the institution.

Grant Mentors

• Quarraisha Abdool Karim, PhD
  HIV treatment and prevention in South Africa; global health; women’s health; interactions between HIV and SARS-CoV-2 in South Africa. 
• Salim Abdool Karim, MBChB, PhD, DSc
  HIV treatment, prevention, and HIV pathogenesis; global health, the impact of COVID-19 on HIV and TB care.
• Delivette Castor, PhD
  Health disparities and implementation science; women’s health; the impact of biomedical, behavioral, and structural factors on disease transmission in resource-limited settings globally and domestically. 
• Dustin Duncan, ScD
  Social and spatial epidemiologist; health disparities and implementation science, impact of neighborhoods and mobility on population health and health disparities.
• Jonathan Dworkin, PhD
  Microbial genomics and pathogenesis.
• Donna Farber, PhD:
  Transplant immunology; anamnestic immune responses to influenza virus and SARS-CoV-2.
• David Fidock, PhD
  Malaria pathogenesis; antimalarial treatment and mechanisms of drug resistance. 
• Stephen Goff, PhD
  Retroviral-host protein interactions, HIV pathogenesis.
• Angela Gomez-Simmonds, MD
  Microbial genomics and pathogenesis, microbial and viral genomics; hospital epidemiology and antimicrobial resistance. 
• David Ho, MD
  Retroviral-host protein interactions; HIV and SARS-CoV-2 pathogenesis and antibody discovery and evolution; strategies to prevent HIV transmission. 
• George Hripcsak, MD, MS
  Biomedical informatics and development of next-generation health record systems. 
• Tal Korem, PhD
  Biomedical informatics, microbial and viral genomics, machine learning, network inference, and metabolic modeling to study host-microbiome interactions. 
• Louise Kuhn, PhD
  Global health, women’s health, HIV treatment and prevention, complications of HIV.
• Ian Lipkin, MD
  Pathogen discovery, global public health.
• Barun Mathema, PhD
  Microbial and viral genomics, hospital epidemiology and antimicrobial resistance; transmission patterns and drug resistance in M. tuberculosis in South Africa.
• Kathrine Meyers, DrPH, MS, MPP
  Health disparities and implementation science; HIV prevention; studying the effective implementation of optimal therapeutic, prophylactic, and diagnostic approaches for infectious diseases (eg HIV, viral hepatitis, coronaviruses). 
• Anne Moscona, MD
  Microbial pathogenesis; antiviral strategies for pediatric respiratory viruses and emerging infections.
• Max O’Donnell, MD, MPH
  Epidemiology and global health of tuberculosis including multi-drug resistant TB in South Africa, HIV, and severe acute respiratory infection.
• Alice Prince, MD
  Microbial pathogenesis, studying virulence genes and adhesins in the pathogenesis of infection in cystic fibrosis.
• Raul Rabadan, PhD
  Biomedical informatics; microbial and viral genomics; studying patterns of evolution in RNA viruses and cancer, and the direct application of computational methods to inform public health policy.
• Robert Remien, PhD
  Biobehavioral interventions for treatment and prevention of HIV; studying the role of health disparities, mental health, substance use, and other social determinants of health on HIV.
• Lisa Saiman, MD
  Hospital epidemiology and antimicrobial resistance;  infection control and prevention across the spectrum of healthcare.
• Jeffrey Shaman, PhD
  Epidemiology and global health; survival, transmission, and ecology of infectious agents; studying effects of meteorological and hydrological conditions on these processes.
• Magda Sobieszczyk, MD, MPH
  HIV treatment and prevention; clinical trials; testing and implementation of biomedical strategies for prevention of HIV.  SARS-CoV-2 epidemiology and vaccines; health disparities and vaccine uptake.
• Megan Sykes, MD
  Transplant immunology; the role of regulatory T cells and of clonal deletion in allograft tolerance.
• Anne-Catrin Uhlemann, MD, PhD
  Microbial pathogenesis, microbial and viral genomics, SARS-CoV-2, microbiome, hospital epidemiology, and antimicrobial resistance.
• Michael Yin, MD, MPH
  HIV treatment and metabolic complications of HIV infection and antiretroviral therapy; epidemiology and pathogenic mechanisms of HIV associated bone loss; epidemiology and pathogenesis of PASC.
• Jason Zucker, MD, MS
  HIV prevention, sexual health; applying technology to optimize the sexual health cascade of care for adolescents and young adults; health disparities.